KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Amgen (AMGN) EPS (Weighted Average and Diluted) (2016 - 2025)

Amgen (AMGN) has 17 years of EPS (Weighted Average and Diluted) data on record, last reported at $2.46 in Q4 2025.

  • For Q4 2025, EPS (Weighted Average and Diluted) rose 112.07% year-over-year to $2.46; the TTM value through Dec 2025 reached $14.23, up 88.48%, while the annual FY2025 figure was $14.23, 88.23% up from the prior year.
  • EPS (Weighted Average and Diluted) reached $2.46 in Q4 2025 per AMGN's latest filing, down from $5.92 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at $5.92 in Q3 2025 and bottomed at -$0.21 in Q1 2024.
  • Average EPS (Weighted Average and Diluted) over 5 years is $2.83, with a median of $2.76 recorded in 2022.
  • Peak YoY movement for EPS (Weighted Average and Diluted): plummeted 103.98% in 2024, then soared 1623.81% in 2025.
  • A 5-year view of EPS (Weighted Average and Diluted) shows it stood at $3.35 in 2021, then decreased by 10.45% to $3.0 in 2022, then plummeted by 52.33% to $1.43 in 2023, then dropped by 18.88% to $1.16 in 2024, then surged by 112.07% to $2.46 in 2025.
  • Per Business Quant database, its latest 3 readings for EPS (Weighted Average and Diluted) were $2.46 in Q4 2025, $5.92 in Q3 2025, and $2.65 in Q2 2025.